Chronic Infections

Condition: Chronic Infections  |  Category: Inflammation and Infectious Health  |  Reviewed by: Brian Lamkin, DO

What Are Chronic Infections?

Chronic infections are persistent pathogen burdens that continue to drive symptoms, inflammation, and immune dysregulation beyond the expected course of acute illness. Unlike acute infection (which resolves), chronic infection persists because the pathogen evades immune clearance, establishes intracellular reservoirs, forms biofilms, reactivates intermittently, or benefits from a host immune environment that is either suppressed or dysregulated. The result is a low-grade infectious burden that produces chronic fatigue, cognitive symptoms, autonomic dysfunction, autoimmune activation, and multisystem inflammation that conventional workups frequently fail to attribute to infection.

The pathogens involved are diverse. Reactivated viruses (Epstein-Barr virus, cytomegalovirus, herpes simplex, HHV-6) account for much of chronic post-viral symptom burden, including many cases of chronic fatigue syndrome. Stealth bacterial pathogens (Borrelia, Bartonella, Mycoplasma, Chlamydia pneumoniae) establish intracellular and tissue reservoirs that evade standard antibiotic courses. Lyme disease and its coinfections represent the best-recognized category. Biofilm-protected gut and oral pathogens contribute to gut dysbiosis and systemic inflammation. Parasites and fungi can persist when immune function is compromised.

Why Chronic Infections Matter

Common Symptoms

Root Causes: A Functional Medicine Perspective

Chronic infection requires both a persistent pathogen and an immune environment that permits persistence. Both must be evaluated.

Reactivated Viral Infections

Epstein-Barr virus, cytomegalovirus, HHV-6, and herpes simplex establish lifelong latency in most adults and reactivate under conditions of immune stress, chronic inflammation, or trauma. Chronic stress with cortisol dysregulation, acute infection (as seen with COVID-19), chemotherapy, or immune-suppressing medications can trigger reactivation. Reactivated EBV is now implicated in chronic fatigue syndrome, multiple sclerosis, and some autoimmune disease presentations. Early EBV antigen antibodies (EA-D) identify active reactivation distinct from past infection.

Stealth Bacterial Pathogens

Borrelia (the cause of Lyme disease), Bartonella, Mycoplasma, and Chlamydia pneumoniae establish intracellular and tissue reservoirs that evade immune clearance and standard antibiotic protocols. These pathogens form biofilms, shift between morphological forms (spirochete to round body in Borrelia), and can persist for years. Co-infections are common and produce overlapping symptom presentations. Expanded testing (PCR, LabCorp and Armin Labs options, immunoblots) identifies what standard testing misses.

Biofilm-Protected Organisms

Chronic gut, sinus, dental, and urinary tract pathogens protected by biofilms resist antimicrobial treatment because the biofilm matrix prevents antibiotic penetration and shields pathogens from immune recognition. SIBO, chronic sinusitis, and recurrent urinary infections frequently involve biofilm-protected organisms that require biofilm-disrupting interventions (nattokinase, serrapeptase, lactoferrin, monolaurin) alongside antimicrobials.

Immune and Metabolic Context

Chronic infection persists when the host immune function is compromised or dysregulated. Vitamin D deficiency, insulin resistance, chronic stress with cortisol dysregulation, mitochondrial dysfunction, methylation defects, and prior pathogen burden all permit continued infection. HLA genetics determine susceptibility to certain biotoxin and infection patterns. Treatment must address the immune and metabolic terrain, not just the pathogen.

Conventional vs Functional Medicine Approach

Key Labs to Evaluate

How to Interpret These Labs Together

Common Patterns Seen in Patients

• The patient with post-infection fatigue that never resolved: had mono at age 19, felt "never fully right" since. Now 45, with chronic fatigue, brain fog, recurrent lymph node swelling, night sweats. EBV VCA IgG elevated, EBV EA-D positive (reactivation marker). Vitamin D 22. Cortisol flattened. This is chronic EBV reactivation with permissive host factors. Antiviral protocol (monolaurin, lysine, astragalus, lauricidin), vitamin D repletion, HPA support, mitochondrial support. Energy improved substantially over 6 to 9 months.
• The patient who was told Lyme was "just anxiety": tick bite 3 years ago, mild rash, treated with 14 days doxycycline. Now with migratory joint pain, POTS, word-finding difficulty, crushing fatigue, heat intolerance. Standard Lyme test negative. Expanded testing (IGeneX immunoblot) showed chronic Borrelia plus Bartonella coinfection. Extended herbal and pharmaceutical antimicrobial protocol alongside immune support and autonomic stabilization. See Lyme disease for full protocol.
• The patient with chronic gut symptoms resistant to standard SIBO treatment: recurrent SIBO with relapse after each rifaximin course. Comprehensive stool analysis identified biofilm-protected pathogens and parasitic coinfection that standard SIBO breath testing missed. Biofilm disruption (nattokinase) plus broader antimicrobial coverage plus gut barrier restoration. Long-term resolution after 4 months of integrated protocol.

Treatment and Optimization Strategy

Integrated Chronic Infection Protocol

What Most Doctors Miss

• Standard testing misses most chronic infections: routine infectious disease panels do not include reactivation markers (EBV EA-D, CMV pp65), stealth pathogen PCR, biofilm-specific organisms, or specialty immunoblots. A "negative workup" frequently means the wrong tests were run.
• Acute paradigm does not apply to chronic infection: 7 to 14 day antibiotic courses are designed for acute, non-protected, non-intracellular infections. Chronic infections with biofilms, intracellular reservoirs, and cyst forms require extended, pulsed, multimodal protocols.
• Treating pathogen without host rarely resolves the problem: if the immune and metabolic terrain permits chronic infection, clearing the pathogen once does not prevent relapse. Host optimization must accompany pathogen treatment.
• Chronic symptoms without obvious cause deserve infection workup: chronic fatigue, brain fog, POTS, and unexplained multisystem symptoms with elevated inflammation warrant expanded chronic infection evaluation before attribution to idiopathic or psychiatric causes.

When to Seek Medical Care

If you experience chronic fatigue that does not resolve, post-exertional malaise, unexplained multisystem symptoms, chronic inflammation of unclear cause, autonomic dysfunction, a history of incomplete recovery from acute infection (mono, Lyme, COVID), or recurrent infections suggesting immune compromise, expanded chronic infection evaluation alongside immune and metabolic assessment is warranted.

Recommended Testing

Frequently Asked Questions

How The Lamkin Clinic Approaches Chronic Infections

At The Lamkin Clinic, chronic infection evaluation includes expanded viral serologies with reactivation markers, stealth pathogen testing when clinically indicated, comprehensive gut pathogen analysis, inflammatory markers (hs-CRP, homocysteine), immune function assessment, and evaluation of the host metabolic terrain (vitamin D, cortisol, fasting insulin). Treatment integrates pathogen-specific antimicrobials, biofilm disruption when indicated, herbal synergists, and host optimization including vitamin D repletion, HPA axis restoration, mitochondrial support, methylation support, and gut restoration.

Related Conditions

Related Symptoms